Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea

This publication has 25 references indexed in Scilit:

• Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania
  Tropical Medicine & International Health, 1999
• Evaluation of SPf66 malaria vaccine efficacy in Brazil.
  The American Journal of Tropical Medicine and Hygiene, 1998
• Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area
  Parasite Immunology, 1997
• Clinical Trials of Malaria Vaccines: Progress and Prospects
  Advances in Parasitology, 1997
• Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand
  The Lancet, 1996
• Assessment of the Role of Naturally Acquired Antibody Levels to Plasmodium falciparum Merozoite Surface Protein-1 in Protecting Papua New Guinean Children from Malaria Morbidity
  The American Journal of Tropical Medicine and Hygiene, 1996
• Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria
  Parasite Immunology, 1995
• Efficacy trial of malaria vaccine SPf66 in Gambian infants
  The Lancet, 1995
• SPf66 - The first malaria vaccine
  Parasitology Today, 1995
• Relationship Between Humoral Response to Plasmodium falciparum Merozoite Surface Antigen-2 and Malaria Morbidity in a Highly Endemic Area of Papua New Guinea
  The American Journal of Tropical Medicine and Hygiene, 1994